Your browser doesn't support javascript.
loading
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks.
Desai, Milind Y; Owens, Anjali; Geske, Jeffrey B; Wolski, Kathy; Saberi, Sara; Wang, Andrew; Sherrid, Mark; Cremer, Paul C; Naidu, Srihari S; Smedira, Nicholas G; Schaff, Hartzell; McErlean, Ellen; Sewell, Christina; Balasubramanyam, Aarthi; Lampl, Kathy; Sehnert, Amy J; Nissen, Steven E.
Afiliação
  • Desai MY; From the Hypertrophic Cardiomyopathy Center (M.Y.D., N.G.S.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Owens A; Department of Cardiovascular Medicine (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Geske JB; Cleveland Clinic Coordinating Center for Clinical Research (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Wolski K; Division of Cardiology, University of Pennsylvania, Philadelphia (A.O.).
  • Saberi S; Departments of Cardiovascular Diseases (J.B.G.), Mayo Clinic, Rochester, MN.
  • Wang A; Department of Cardiovascular Medicine (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Sherrid M; Cleveland Clinic Coordinating Center for Clinical Research (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Cremer PC; Department of Internal Medicine, University of Michigan, Ann Arbor (S.S.).
  • Naidu SS; Department of Cardiology, Duke University, Durham, NC (A.W.).
  • Smedira NG; Department of Cardiology, New York University, NY (M.S.).
  • Schaff H; Department of Cardiovascular Medicine (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • McErlean E; Cleveland Clinic Coordinating Center for Clinical Research (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Sewell C; Department of Cardiology, Westchester Medical Center, Valhalla, NY (S.S.N.).
  • Balasubramanyam A; From the Hypertrophic Cardiomyopathy Center (M.Y.D., N.G.S.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Lampl K; Department of Cardiothoracic Surgery (N.G.S.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
  • Sehnert AJ; Cardiovascular Surgery (H.S.), Mayo Clinic, Rochester, MN.
  • Nissen SE; Department of Cardiovascular Medicine (M.Y.D., K.W., P.C.C., E.M., C.S., S.E.N.), Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.
Circulation ; 147(11): 850-863, 2023 03 14.
Article em En | MEDLINE | ID: mdl-36335531
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Função Ventricular Esquerda Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Função Ventricular Esquerda Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article